Importantly, the proinflammatory activation mechanisms for NFκB and ENaC signaling in CF are well known, and depend on the presence of inactivating mutations in CFTR, the Cystic Fibrosis Transmembrane Conductance Regulator9. The gene discussed is NFKB1; the disease is cystic fibrosis.